Metabolic Blood Test Pattern May Predict Post-Stroke Depression Risk

Post-stroke depression (PSD) is one of the most common neuropsychiatric complications among stroke survivors, significantly affecting rehabilitation adherence and long-term clinical outcomes. Although previous studies have examined the roles of either functional impairment or metabolic dysregulation in PSD, limited research has explored their combined impact from an integrative perspective. Now, a new study published in Frontiers in Psychiatry has taken a major step forward by combining these two domains into a single analytical framework, revealing that the interplay between a patient’s physical independence and their metabolic health may be a decisive factor in determining who develops depression after a stroke.

The research team, led by investigators at Nantong First People’s Hospital and Southeast University in China, enrolled 245 consecutive patients admitted with acute ischemic stroke between June 2023 and December 2024. Of these, 65 were diagnosed with PSD within the first month after their stroke, using the 24-item Hamilton Depression Rating Scale and DSM-5 diagnostic criteria. The study focused on two key metabolic markers: the atherogenic index of plasma (AIP), which reflects lipid metabolism and atherosclerotic risk, and the triglyceride-glucose (TyG) index, a reliable surrogate for insulin resistance. Functional status was assessed using the Barthel Index, a widely adopted tool that measures activities of daily living such as eating, dressing, and walking.

Compared with non-PSD patients, those with PSD showed significantly lower Barthel Index scores and higher TyG and AIP levels. Restricted cubic spline (RCS) analysis indicated a nonlinear relationship between AIP and PSD risk, with the odds ratio increasing more markedly at higher AIP values. The researchers identified an approximate turning point at an AIP value of 0.26, beyond which the risk of depression showed a clear upward trend. This finding suggests that AIP may trigger inflammatory or endocrine cascades only beyond a certain threshold, a pattern that linear models can undershoot.

Multivariate logistic regression identified the Barthel Index (OR = 0.97, 95% CI: 0.95–0.99) and the TyG Index (OR = 2.04, 95% CI: 1.19–3.47) as independent predictors of PSD. These results confirm that both functional impairment and metabolic dysregulation carry distinct associations with post-stroke depression. The Barthel Index reflects not only reduced self-care ability but also the psychological burden and reduced confidence in recovery that accompany physical dependence. Insulin resistance, indexed by TyG, is tightly linked to inflammation and oxidative stress and may provoke depressive symptoms by disrupting neurotransmitter metabolism and neuroplasticity.

The most innovative aspect of the study was the application of partial least squares (PLS) regression combined with K-means clustering to categorize stroke patients based on integrated functional and metabolic indicators, including the Barthel Index, body mass index (BMI), AIP, and TyG Index. This approach revealed four distinct functional–metabolic subtypes: a physiological protection subtype (preserved function with optimal metabolic indices), a subclinical burden subtype (largely intact function with mild metabolic abnormalities), a metabolic susceptibility subtype (acceptable function but markedly elevated TyG and AIP), and a dual-impaired subtype (pronounced functional impairment accompanied by metabolic abnormalities).

Patients in the metabolic susceptibility subtype and the dual-impaired subtype had significantly higher risks of PSD compared to the reference group. The metabolic susceptibility subtype showed an odds ratio of 2.13 (95% CI: 1.02–4.46), while the dual-impaired subtype showed an odds ratio of 2.63 (95% CI: 1.16–5.96). Notably, the dual-impaired subtype exhibited the highest incidence of PSD at 46%, suggesting that the combined effects of significant functional impairment and metabolic dysregulation create a particularly vulnerable psychological state.

The metabolic susceptibility subtype demonstrated unique risk features. Despite exhibiting relatively preserved functional status, this subtype showed a markedly elevated metabolic burden alongside a PSD incidence of 32.08%. These findings suggest that even in the absence of overt functional impairments, underlying inflammatory and oxidative stress may increase vulnerability to post-stroke depression. Previous research has reported strong associations between TyG and increased white blood cell counts or high-sensitivity C-reactive protein levels, suggesting a potential inflammatory pathway linking metabolic dysregulation to PSD risk.

Inflammatory mechanisms are central to ischemic brain injury, and an imbalance between pro- and anti-inflammatory mediators can worsen neurological outcomes. Such dysregulation has been implicated in both PSD and primary major depressive disorder, suggesting potentially shared biological pathways. Recent animal studies further support this pathological pathway: following stroke, alleviating hippocampal inflammation promotes neuronal repair and significantly improves depressive-like symptoms in post-stroke mouse models. Metabolic dysregulation further amplifies this cascade by provoking oxidative stress, compromising blood–brain barrier integrity, and exacerbating neuro-inflammation.

The dual-impaired subtype was characterized by severe dysfunction and pronounced metabolic abnormalities. Patients in this group may be particularly susceptible to psychological distress due to the combined effects of significant functional impairment—which fosters dependency and social isolation—and metabolic dysregulation such as insulin resistance and dyslipidemia. These coexisting conditions can jointly disrupt emotional regulation, resulting in heightened psychophysiological vulnerability. Previous research has demonstrated that impairments in activities of daily living not only reflect substantial neurological damage but also indicate the need for considerable assistance with basic life tasks, often leading to negative emotional states including feelings of helplessness and social withdrawal.

This study is the first to apply PLS-K-means clustering to categorize stroke patients based on integrated functional and metabolic indicators, revealing substantial heterogeneity across patients. The findings underscore the importance of simultaneously assessing functional status and metabolic phenotype in the early stages following stroke. Incorporating both functional and metabolic assessments into early screening strategies may support the development of more targeted psychological interventions tailored to specific patient phenotypes, thereby reducing PSD incidence and improving long-term outcomes. However, the researchers acknowledge several limitations, including the cross-sectional nature of the study, the relatively limited sample size, and the single assessment window within the first month after stroke, which precludes inference of causal relationships and may not capture the temporal evolution of depressive symptoms.

Subject of Research: Combined effect of functional impairment and metabolic dysregulation on post-stroke depression risk

Article Title: Combined effect of functional impairment and metabolic dysregulation on post-stroke depression risk

Article References: Zhang, T., Shi, W., Chi, Q., Qian, J., Wang, T., Zhu, L., Ding, W., & Chen, Z. (2026). Combined effect of functional impairment and metabolic dysregulation on post-stroke depression risk. Frontiers in Psychiatry, 17, Article 1843802. https://doi.org/10.3389/fpsyt.2026.1843802

Image Credits: AI Generated

DOI: 10.3389/fpsyt.2026.1843802

Keywords: Combined, effect, functional, impairment, metabolic, dysregulation, post-stroke, depression, risk, scientific research